Chapter 1 Ginsenosides. Chemistry, Biosynthesis, Analysis, and Potential Health Effects

Advances in Food and Nutrition Research

Volumn 55, Issue , 2008, Pages 1-99

  Christensen, Lars P ^a  

^a DANISH INSTITUTE OF AGRICULTURAL SCIENCES   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; GINSENOSIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT;

BIOSYNTHESIS; CAPILLARY ELECTROPHORESIS; CHEMISTRY; CHROMATOGRAPHY; ENZYME IMMUNOASSAY; GINSENG; HUMAN; METABOLISM; METHODOLOGY; NEAR INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYTOTHERAPY; REVIEW;

ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; ANTIHYPERTENSIVE AGENTS; CHROMATOGRAPHY; ELECTROPHORESIS, CAPILLARY; GINSENOSIDES; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOENZYME TECHNIQUES; MAGNETIC RESONANCE SPECTROSCOPY; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; SPECTROSCOPY, NEAR-INFRARED;

EID: 50349101675     PISSN: 10434526     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1043-4526(08)00401-4     Document Type: Review

References (347)

1. Abe I., Rohmer M., and Prestwich G.D. Enzymatic cyclization of squalene and oxidosqualene to sterols and triterpenes. Chem. Rev. 93 (1993) 2189-2206
2. Ackloo S.Z., Smith R.W., Terlouw J.K., and McCarry B.E. Characterization of ginseng saponins using electrospray mass spectrometry and collision-induced dissociation experiments of metal-attachment ions. Analyst 125 (2000) 591-597
3. 1 to compound K by Eubacterium sp. A44, a human intestinal bacterium and absorption of compound K. Ginseng Rev. 24 (1997) 1-7
4. 1 from Panax ginseng. J. Pharm. Pharmacol. 50 (1998) 1155-1160
5. Anderson M.L., and Burney D.P. Validation of sample preparation procedures for botanical analysis. J. AOAC Int. 81 (1998) 1005-1010
6. Asafu-Adjaye E.B., and Wong S.K. Determination of ginsenosides (ginseng saponins) in dry root powder from Panax ginseng, Panax quinquefolius, and selected commercial products by liquid chromatography: Interlaboratory study. J. AOAC Int. 86 (2003) 1112-1123
7. Attele A.S., Wu J.A., and Yuan C.-S. Ginseng pharmacology. Multiple constituents and multiple actions. Biochem. Pharmacol. 58 (1999) 1685-1693
8. Attele A.S., Zhou Y.P., Xie J.T., Wu J.A., Zhang L., Dey L., Pugh W., Rue P.A., Polonsky K.S., and Yuan C.S. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 51 (2002) 1851-1858
9. Auwerx J., Schoonjans K., Fruchart J.C., and Staels B. Transcriptional control of triglyceride metabolism: Fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR. Atherosclerosis 124 Suppl. (1996) S29-S37
10. Azuma I., and Mochizuki M. Inhibition of tumor cell invasion and metastasis by ginsenosides. Ginseng Rev. 18 (1994) 37-39
11. b2 from human intestinal bacteria. Biol. Pharm. Bull. 23 (2000) 1481-1485
12. 3 by human intestinal bacteria and its relation to in vitro biological activities. Biol. Pharm. Bull. 25 (2002) 58-63
13. 2 by acids and human intestinal bacteria and biological activities of their transformations. Arch. Pharm. Res. 27 (2004) 61-67
14. Bae E.-A., Kim E.-J., Park J.-S., Kim H.-S., Ryu J.H., and Kim D.-H. Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-γ-stimulated BV-2 microglial cells. Planta Med. 72 (2006) 627-633
15. Barroso I., Gurnell M., Crowley V.E.F., Agostini M., Schwabel J.W., Soos M.A., Maslen G.L.I., Williams T.D.M., Lewis H., Schafer A.J., Chatterjee V.K.K., and O'Rahilly S. Dominant negative mutations in human PPAR γ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402 (1999) 880-883
16. Bays H., Mandarino L., and DeFronzo R.A. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proleferator-activated receptor agonists provide a rational therapeutic approach. J. Clin. Endocrinol. Metab. 89 (2004) 463-478
17. 1 on choline uptake in central cholinergic nerve endings. Neurochem. Int. 21 (1992) 1-5
18. 1 on central cholinergic metabolism. Pharmacology 42 (1991) 223-229
19. 2, new dammarane saponins of ginseng roots. Chem. Pharm. Bull. 30 (1982) 2380-2385
20. Bharti A.C., and Aggarwal B.B. Nuclear factor-κB and cancer: Its role in prevention and therapy. Biochem. Pharmacol. 64 (2002) 883-888
21. Bilia A.R., Bergonzi M.C., Mazzi G., and Vincieri F.F. Analysis of plant complex matrices by use of nuclear magnetic resonance spectroscopy: St. John's wort extract. J. Agric. Food Chem. 49 (2001) 2115-2124
22. 2 arnica extracts. J. Pharm. Biomed. Anal. 30 (2002) 321-330
23. Blagg B.S.J., Jarstfer M.B., Rogers D.H., and Poulter C.D. Recombinant squalene synthase. A mechanism for the rearrangement of presqualene diphosphate to squalene. J. Am. Chem. Soc. 124 (2002) 8846-8853
24. Bombardelli E., Bonati A., Gabetta B., and Martinelli E.M. Gas-liquid chromatographic method for the determination of ginsenosides in Panax ginseng. J. Chromatogr. 196 (1980) 121-132
25. Burgermeister E., Schnoebelen A., Flament A., Benz J., Stihle M., Gsell B., Rufer A., Ruf A., Kuhn B., Märki H.P., Mizrahi J., Sebokova E., et al. A novel agonist of peroxiome proliferator-activated receptor-γ (PPAR γ) recruits PPAR γ-coactivator-1α, prevents triglyceride accumulation, and potentiates insuling signalling in vitro. Mol. Endocrinol. 20 (2006) 809-830
26. Cai Z., Lee F.S.C., Wang X.R., and Yu W.J. A capsule review of recent studies on the application of mass spectrometry in the analysis of Chinese medicinal herbs. J. Mass Spectrom. 37 (2002) 1013-1024
27. Cao X.-L., Tian Y., Zhang T.-Y., Liu Q.-H., Jia L.-J., and Ito Y. Separation of dammarane-saponins from notoginseng, root of Panax notoginseng (Burk.) F. H. Chen, by HSCCC coupled with evaporative light scattering detector. J. Liq. Chromatogr. Rel. Technol. 26 (2003) 1579-1591
28. Chan T.W.D., But P.P.H., Cheng S.W., Kwok I.M.Y., Lau F.W., and Xu H.X. Differentiation and authentication of Panax ginseng, Panax quinquefolius, and ginseng products by using HPLC/MS. Anal. Chem. 72 (2000) 1281-1287
29. Chan E.C.Y., Yap S.-L., Lau A.-J., Leow P.-C., Toh D.-F., and Koh H.-L. Ultra-performance liquid chromatography/time-of-flight mass spectrometry based metabolomics of raw and steamed Panax notoginseng. Rapid Commun. Mass Spectrom. 21 (2007) 519-528
30. Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin. Exp. Pharmacol. Physiol. 23 (1996) 728-732
31. Chen Y., and Sorensen L.K. Determination of marker constituents in radix Glycyrrhizae and radix Notoginseng by near infrared spectroscopy. Fresenius J. Anal. Chem. 367 (2000) 491-496
32. Chen J., Xie M., Fu Z., Lee F.S.-C., and Wang X. Development of a quality evaluation system for Panax quinquefolium L. based on HPLC chromatographic fingerprinting of seven major ginsenosides. Microchem. J. 85 (2007) 201-208
33. Chi H., Kim D.-H., and Ji G.-E. Transformation of ginsenosides Rb2 and Rc from Panax ginseng by food microorganisms. Biol. Pharm. Bull. 28 (2005) 2102-2105
34. Cho J.Y., Yoo E.S., Baik K.U., Park M.H., and Han B.H. In vitro inhibitory effect of protopanaxadiol ginsenosides on tumor necrosis factor (TNF)-α production and its modulation by known TNF-α antagonists. Planta Med. 67 (2001) 213-218
35. Cho J.Y., Kim A.R., Yoo E.S., Baik K.U., and Park M.H. Ginsenosides from Panax ginseng differentially regulate lymphocyte proliferation. Planta Med. 68 (2002) 497-500
36. Cho W.C.S., Chung W.-S., Lee S.K.W., Leung A.W.N., Cheng C.H.K., and Yue K.K.M. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 550 (2006) 173-179
37. Choi H.-K., and Wen J. A phylogenetic analysis of Panax (Araliaceae): Integrating cpDNA restriction site and nuclear rDNA ITS sequence data. Plant Syst. Evol. 224 (2000) 109-120
38. Choi D.-W., Jung J., Ha Y.I., Park H.-W., In D.S., Chung H.-J., and Liu J.R. Analysis of transcripts in methyl jasmonate-treated ginseng hairy roots to identify genes involved in the biosynthesis of ginsenosides and other secondary metabolites. Plant Cell Rep. 23 (2005) 557-566
39. Choo K.-M., Park E.-K., Han M.J., and Kim D.-H. Antiallergic activity of ginseng and its ginsenosides. Planta Med. 69 (2003) 518-522
40. Christensen L.P., and Brandt K. Bioactive polyacetylenes in food plants of the Apiaceae family: Occurrence, bioactivity and analysis. J. Pharm. Biomed. Anal. 41 (2006) 683-693
41. Christensen L.P., Jensen M., and Kidmose U. Simultaneous determination of ginsenosides and polyacetylenes in American ginseng root (Panax quinquefolium L.) by high-performance liquid chromatography. J. Agric. Food Chem. 54 (2006) 8995-9003
42. Chuang W.-C., and Sheu S.-J. Determination of ginsenosides in ginseng crude extracts by high-performance liquid chromatography. J. Chromatogr. A 685 (1994) 243-251
43. Chuang W.-C., Wu H.-K., Sheu S., Chiou S.-H., Chang H.-C., and Chen Y.-P. A comparative study on commercial samples of ginseng-radix. Planta Med. 61 (1995) 459-465
44. Chung S.H., Choi C.G., and Park S.H. Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Arch. Pharm. Res. 24 (2001) 214-218
45. Corbit R.M., Ferreira J.F.S., Ebbs S.D., and Murphy L.L. Simplified extraction of ginsenosides from American ginseng (Panax quinquefolius L.) for high-performance liquid chromatography-ultraviolet analysis. J. Agric. Food Chem. 53 (2005) 9867-9873
46. Corthout J., Naessens T., Apers S., and Vlietinck. Quantitative determination of ginsenosides from Panax ginseng roots and ginseng preparations by thin layer chromatography-densitometry. J. Pharm. Biomed. Anal. 21 (1999) 187-192
47. Court W.A., Hendel J.G., and Elmi J. Reversed-phase high-performance liquid chromatographic determination of ginsenosides of Panax quinquefolium. J. Chromatogr. A 755 (1996) 11-17
48. Court W.A., Reynolds L.B., and Hendel J.G. Influence of root age on the concentration of ginsenosides of American ginseng (Panax quinquefolium). Can. J. Plant Sci. 76 (1996) 853-855
49. Cui J.-F. Identification and quantification of ginsenosides in various commercial ginseng preparations. Eur. J. Pharm. Sci. 3 (1995) 77-85
50. Cui J.-F., Garle M., Lund E., Björkhem I., and Eneroth P. Analysis of ginsenosides by chromatography and mass spectrometry: Release of 20 S-protopanaxadiol and 20 S-protopanaxatriol for quantification. Anal. Biochem. 210 (1993) 411-417
51. Cui J.-F., Garle M., Björkhem I., and Eneroth P. Determination of aglycones of ginsenosides in ginseng preparations sold in Sweeden and in urine samples from Swedish athletes consuming ginseng. Scand. J. Clin. Lab. Invest. 56 (1996) 151-160
52. Cui J.-F., Björkhem I., and Eneroth P. Gas chromatographic-mass spectrometric determination of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol for study on human urinary excretion of ginsenosides after ingestion of ginseng preparations. J. Chromatogr. B 689 (1997) 349-355
53. Cui J.-F., Eneroth P., Bruhn J.G., Arihara S., and Yoshikawa K. Alkaline cleavage of gypenosides and characterization of dammarane-type aglycones by gas chromatography-mass spectrometry. Phytochem. Anal. 9 (1998) 128-133
54. Cui J.-F., Eneroth P., and Bruhn J.G. Gymnostemma pentaphyllum: Identification of major sapogenins and differentiation from Panax species. Eur. J. Pharm. Sci. 8 (1999) 187-191
55. Cui M., Song F., Zhou Y., Liu Z., and Liu S. Rapid identification of saponins in plant extracts by electrospray ionization multi-stage tandem mass spectrometry and liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 14 (2000) 1280-1286
56. Cui M., Song F., Liu Z., and Liu S. Metal ion adducts in the structural analysis of ginsenosides by electrospray ionization with multi-stage mass spectrometry. Rapid Commun. Mass Spectrom. 15 (2001) 586-595
57. Dallenbach-Toelke K., Nyiredy S., Mészáros S.Y., and Sticher O. TLC, HPTLC, and OPTLC separation of ginsenosides. J. High Resolut. Chromatogr. Chromatogr. Commun. 10 (1987) 362-364
58. Davidson V.J., Li X., and Brown R.B. Forced-air drying of ginseng roots: 2. Control strategy for three-stage drying process. J. Food Eng. 63 (2004) 369-373
59. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocrine Rev. 20 (1999) 649-688
60. nd Ed (2004), John Wiley & Sons., New York
61. Dou D.-Q., Chen Y.-J., Liang L.-H., Pang F.-G., Shimizu N., and Takeda T. Six new dammarane-type triterpene saponins from the leaves of Panax ginseng. Chem. Pharm. Bull. 49 (2001) 442-446
62. 8, a new dammarane-type triterpenoid saponin from roots of Panax quinquefolium. Chem. Pharm. Bull. 54 (2006) 751-753
63. Du X.W., Wills R.B.H., and Stuart D.L. Changes in neutral and malonyl ginsenosides in American ginseng (Panax quinquefolium) during drying, storage and ethanolic extraction. Food Chem. 86 (2004) 155-159
64. Duc N.M., Nham N.T., Kasai R., Ito A., Yamasaki K., and Tanaka O. Saponins from Vietnamese ginseng, Panax vietnamensis Ha et Grushv. Collected in central Vietnam. I. Chem. Pharm. Bull. 41 (1993) 2010-2014
65. Duc N.M., Kasai R., Ohtani K., Ito A., Nham N.T., Yamasaki K., and Tanaka O. Saponins from Vietnamese ginseng, Panax vietnamensis Ha et Grushv. Collected in central Vietnam. II. Chem. Pharm. Bull. 42 (1994) 115-122
66. Duc N.M., Kasai R., Ohtani K., Ito A., Nham N.T., Yamasaki K., and Tanaka O. Saponins from Vietnamese ginseng, Panax vietnamensis Ha et Grushv. Collected in central Vietnam. III. Chem. Pharm. Bull. 42 (1994) 634-640
67. Fan T.-P., Yeh J.-C., Leung K.W., Yue P.Y.K., and Wong R.N.S. Angiogenesis: From plants to blood vessels. Trends Pharmacol. Sci. 27 (2006) 297-309
68. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1 (1995) 27-31
69. Fukuda N., Tanaka H., and Shoyama Y. Western blotting for ginseng saponins, ginsenosides using anti-ginsenoside Rb1 monoclonal antibody. Biol. Pharm. Bull. 22 (1999) 219-220
70. Fukuda N., Tanaka H., and Shoyama Y. Fomation of monoclonal antibody against a major ginseng component, ginsenoside Rg1 and its characterisation. Monoclonal antibody for a ginseng saponin. Cytotechnology 34 (2000) 197-204
71. Fukuda N., Tanaka H., and Shoyama Y. Applications of ELISA, Western blotting and immunoaffinity concentration for survey of ginsenosides in crude drugs of Panax species and traditional Chinese herbal medicines. Analyst 125 (2000) 1425-1429
72. Fukuda N., Tanaka H., and Shoyama Y. Double staining of ginsenosides by western blotting using anti-ginsenoside Rb1 and Rg1 monoclonal antibodies. Biol. Pharm. Bull. 24 (2001) 1157-1160
73. Fuzzati N. Analysis methods of ginsenosides. J. Chromatogr. B 812 (2004) 119-133
74. Fuzzati N., Gabetta B., Jayakar K., Pace R., and Peterlongo F. Liquid chromatography-electrospray mass spectrometric identification of ginsenosides in Panax ginseng roots. J. Chromatogr. A 854 (1999) 69-79
75. Fuzzati N., Gabetta B., Jayakar K., Pace R., Ramaschi G., and Villa F. Determination of ginsenosides in Panax ginseng roots by liquid chromatography with evaporative light-scattering detection. J. AOAC Int. 83 (2000) 820-829
76. Gadient R.A., and Otten U.H. Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials. Prog. Neurobiol. 52 (1997) 379-390
77. Gillis C.N. Panax ginseng pharmacology: A nitric oxide link?. Biochem. Pharmacol. 54 (1997) 1-8
78. Glensk M., Czekalska M., and Cisowski W. Resolution of saponins from a ginseng preparation by 2D TLC with an adsorbant gradient. J. Planar Chromatogr. 14 (2001) 454-456
79. Glöckl I., Veit M., and Blaschke G. Determination of ginsenosides from Panax ginseng using micellar electrokinetic chromatography. Planta Med. 68 (2002) 158-161
80. Haijiang Z., Yongjiang W., and Yiyu C. Analysis of "SHENMAI" injection by HPLC/MS/MS. J. Pharm. Biomed. Anal. 31 (2003) 175-183
81. Han B.H., Park M.H., Han Y.N., Woo L.K., Sankawa U., Yahara S., and Tanaka O. Degradation of ginseng saponins under mild acidic conditions. Planta Med. 44 (1982) 146-149
82. Han H.J., Yoon B.C., Lee S.H., Park S.H., Park J.Y., Oh Y.J., and Lee Y.J. Ginsenosides inhibit EGF-induced proliferation of renal proximal tubule cells via decrease of c-fos and c-jun gene expression in vitro. Planta Med. 68 (2002) 971-974
83. Han L.K., Zheng Y.N., Yoshikawa M., Okuda H., and Kimura Y. Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes. BMC Complement Altern. Med. 5 (2005) 9
84. Han K.L., Jung M.H., Sohn J.H., and Hwang J.-K. Ginsenoside 20(S)-protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor γ (PPARγ) in 3T3-L1 adipocytes. Biol. Pharm. Bull. 29 (2006) 110-113
85. Haralampidis K., Trojanowska M., and Osbourn A.E. Biosynthesis of triterpenoid saponins in plants. Adv. Biochem. Eng. Biotechnol. 75 (2001) 31-49
86. Hasegawa H., Sung J.-H., Matsumiya S., and Uchiyama M. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med. 62 (1996) 453-457
87. Hasegawa H., Sung J.-H., and Benno Y. Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Planta Med. 63 (1997) 436-440
88. Hasegawa H., Lee K.S., Nagaoka T., Tezuka Y., Uchiyama M., Kadota S., and Saiki I. Pharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its transformation to biologically active fatty acid esters. Biol. Pharm. Bull. 23 (2000) 298-304
89. Hasegawa H., Suzuki R., Nagaoka T., Tezuka Y., Kadota S., and Saiki I. Prevention of growth and metastasis of murine melanoma through enhanced natural-killer cytotoxicity by fatty acid-conjugate of protopanaxatriol. Biol. Pharm. Bull. 25 (2002) 861-866
90. Hertz R., Bishara-Schieban J., and Bar-Tana. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J. Biol. Chem. 270 (1995) 13470-13475
91. Iwagami S., Sawabe Y., and Nakagawa T. Micellar electrokinetic chromatography for the analysis of crude drugs (III): Separation of ginsenosides in ginseng radix. Shoyakugaku Zasshi 46 (1992) 339-347
92. Jeoung M.K., Chung Y.B., Lee P.S., Kim C.S., Kim N.H., Son D.J., and Hong J.T. Determination of a ginseng saponin metabolite, IH901, in rat plasma by liquid chromatography-tandem mass spectrometry. J. Liq. Chromatogr. Rel. Technol. 28 (2005) 3205-3216
93. Ji Q.C., Harkey M.R., Henderson G.L., Gershwin M.E., Stern J.S., and Hackman R.M. Quantitative determination of ginsenosides by high performance liquid chromatography-tandem mass spectrometry. Phytochem. Anal. 12 (2001) 320-326
94. Jin Y.H., Yoo K.J., Lee Y.H., and Lee S.K. Caspase 3-mediated cleavage of p21 (WAF1/CIP1) associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. J. Biol. Chem. 275 (2000) 30256-30263
95. Joo S.S., Won T.J., and Lee D.I. Reciprocal activity of ginsenosides in the production of proinflammatory repertoire, and their potential roles in neuroprotection in vitro. Planta Med. 71 (2005) 476-481
96. Jung K.Y., Kim D.S., Oh S.R., Lee I.S., Lee J.J., Park J.D., Kim S., and Lee H.-K. Platelet activating factor antagonist activity of ginsenosides. Biol. Pharm. Bull. 21 (1998) 79-80
97. Jung D.-W., Lee J.M., and Sung C.K. Enzyme-linked immunosorbent assay for determination of 20(S)-protopanaxatriol. Anal. Chim. Acta 462 (2002) 157-163
98. Jung J.D., Park H.-W., Hahn Y., Hur C.-G., In D.S., Chung H.-J., Liu J.R., and Choi D.W. Discovery of genes for ginsenoside biosynthesis by analysis of ginseng expressed sequence tags. Plant Cell Rep. 22 (2003) 224-230
99. 1 from Panax ginseng. Chem. Pharm. Bull. 40 (1992) 314-317
100. Kang S.Y., Kim S.H., Schini-Kerth V.B., and Kim N.D. Dietary ginsenosides improve endothelium-dependent relaxation in the thoratic aorta of hypercholesterolemic rabbit. Gen. Pharmacol. 26 (1995) 483-487
101. Kang S.Y., Schini-Kerth V.B., and Kim N.D. Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta. Life Sci. 56 (1995) 1577-1586
102. + channel regulation. Biochem. Biophys. Res. Commun. 333 (2005) 1194-1201
103. Kenarova B., Neychev H., Hadjiivanova C., and Petkov V.D. Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. Jpn. J. Pharmacol. 54 (1990) 447-454
104. 2 and adjuvant effects of cisplatin in vivo. Anticancer Drugs 2 (1991) 63-67
105. Kim N.D., Kang S.Y., and Schini V.B. Ginsenosides evoke endothelium-dependent vascular relaxation in rat aorta. Gen. Pharmac. 25 (1994) 1071-1077
106. Kim D., Chang Y.-J., Zedk U., Zhao P., Liu Y.-Q., and Yang C.-R. Dammarane saponins from Panax ginseng. Phytochemistry 40 (1995) 1493-1497
107. 5, a genuine dammarane glycoside from Korean red ginseng. Arch. Pharm. Res. 19 (1996) 551-553
108. Kim D.H., Jung J.S., Suh H.W., Huh S.O., Min S.K., Son B.K., Park J.H., Kim N.D., Kim Y.H., and Song D.K. Inhibition of stress-induced plasma cortocosterone levels by ginsenosides in mice: Involvement of nitric oxide. Neuroreport 9 (1998) 2261-2264
109. 3 protect cultured rat cortical cells from glutamate-induced neurodegeneration. J. Neurosci. Res. 53 (1998) 426-432
110. WAF1 leading to induction of apoptosis in SK-HEP-1 cells. Anticancer Res. 19 (1999) 487-491
111. WAF1 in human heptoma SK-HEP-1 cells. Eur. J. Cancer 35 (1999) 507-511
112. L-independent pathway. Life Sci. 65 (1999) PL33-PL40
113. Kim W.Y., Kim J.M., Han S.B., Lee S.K., Kim N.D., Park M.K., Kim C.K., and Park J.H. Steaming of ginseng at high temperatures enhances biological activity. J. Nat. Prod. 63 (2000) 1702-1704
114. Kim S., Ahn K., Oh T.H., Nah S.-Y., and Rhim H. Inhibitory effect of ginsenosides on NMDA receptor-mediated signals in rat hippocampal neurons. Biochem. Biophys. Res. Commun. 296 (2002) 247-254
115. Kim C.S., Park J.B., Kim K.J., Chang S.J., Ryoo S.W., and Jeon B.H. Eefect of Korea red ginseng on cerebral blood flow and superoxide production. Acta Pharmacol. Sin. 23 (2002) 1152-1156
116. Kim D.-H., Jung J.-S., Moon Y.-S., Sung J.-H., Suh H.-W., Kim Y.-H., and Song D.-K. Inhibition of intracerebroventricular injection stress induced plasma corticosterone levels by intracerebroventricularly administered compound K, a ginseng saponin metabolite, in mice. Biol. Pharm. Bull. 26 (2003) 1035-1038
117. Kim D.-H., Moon Y.-S., Lee T.-H., Jung J.-S., Suh H.-W., and Song D.-K. The inhibitory effect of ginseng saponins on the stress-induced plasma interleukin-6 level in mice. Neurosci. Lett. 353 (2003) 13-16
118. Kim J.H., Hahm D.H., Yang D.C., Kim J.H., Lee H.J., and Shim I. Effect of crude saponin of Korean red ginseng on high-fat diet-induced obesity in the rat. J. Pharm. Sci. 97 (2005) 124-131
119. Kim J.-H., Kim S., Yoon I.-S., Lee J.-H., Jang B.-J., Jeong S.M., Lee J.-H., Lee B.-H., Han J.-S., Oh S., Kim H.-C., Park T.K., et al. Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats. Neuropharmacology 48 (2005) 743-756
120. Kim B.-H., Lee S.-Y., Cho H.-J., You S.-N., Kim Y.-J., Park Y.-M., Lee J.-K., Baik M.-Y., Park C.-S., and Ahn S.-C. Biotransformation of Korean Panax ginseng by Pectinex. Biol. Pharm. Bull. 29 (2006) 2472-2478
121. B receptors. Gen. Pharmacol. 25 (1994) 193-199
122. Kimura Y., Okuda H., and Arichi S. Effects of various ginseng saponins on 5-hydroxytryptamine release and aggregation in human platelets. J. Pharm. Pharmacol. 40 (1988) 838-843
123. Kitagawa I., Yoshikawa M., Yoshigara M., Hayashi T., and Taniyama T. Chemical studies on crude drug precession. I. On the constitution of ginseng radix rubra. Yakugaku Zasshi 103 (1983) 612-622
124. Kitagawa I., Kobayashi M., Akedo H., Tatsuta M., Iishi H., Shinkai K., Mukai M., and Imamura F. Inhibition of tumor cell invasion and metastasis by ginsenoside Rg-3. Ginseng Rev. 20 (1995) 41-46
125. Kite G.C., Howes M.-J.R., Leon C.J., and Simmonds M.S.J. Liquid chromatography/mass spectrometry of malonyl-ginsenosides in the authentication of ginseng. Rapid Commun. Mass Spectrom. 17 (2003) 238-244
126. Kohda H., Tanaka S., Yamaoka Y., Izumi H., Nuno M., Isoda S., Gotoh K., Watanabe T., Katsuki S., and Satake M. Chikusetsusaponin. VI. A new saponin from the rhizome of Panax pseudo-ginseng var. angustatus Hara. Chem. Pharm. Bull. 39 (1991) 1588-1590
127. Komakine N., Okasaka M., Takaishi Y., Kawazoe K., Murakami K., and Yamada Y. New dammarane-type saponin from roots of Panax notoginseng. J. Nat. Med. 60 (2006) 135-137
128. Kondo N., Marumoto Y., and Shoji J. Studies on the constituents of Panacis japonici rhizoma. V. Structure of chikusetsusaponin V. Chem. Pharm. Bull. 19 (1971) 1103-1107
129. Kushiro T., Ohno Y., Shibuya M., and Ebizuka Y. In vitro conversion of 2,3-oxidosqualene into dammarenediol by Panax ginseng microsomes. Biol. Pharm. Bull. 20 (1997) 292-294
130. Kuwahara M., Kawanishi F., Komiya T., and Oshio H. Dammarane saponins of Gynostemma pentaphyllum Makino and isolation of malonylginsenosides-Rb1,- Rd, and malonylgypenoside V. Chem. Pharm. Bull. 37 (1989) 135-139
131. Kwon S.W., Han S.B., Park I.H., Kim J.M., Park M.K., and Park J.H. Liquid chromatographic determination of less polar ginsenosides in processed ginseng. J. Chromatogr. A 921 (2001) 335-339
132. Kwon J.-H., Bélanger J.M.R., Paré J.R.J., and Yaylayan V.A. Application of the microwave-assisted process (MAP™) to the fast extraction of ginseng saponins. Food Res. Int. 36 (2003) 491-498
133. Lai C.M., Li S.P., Yu H., Wan J.B., Kan K.W., and Wang Y.T. A rapid HPLC-ESI-MS/MS for qualitative and quantitative analysis of saponins in "XUESETONG" injection. J. Pharm. Biomed. Anal. 40 (2006) 669-678
134. Larsen T.M., Toubro S., and Astrup A. PPAR gamma agonists in the treatment of type II diabetes: Is increased fatness commensurate with long-term efficacy?. Int. J. Obesity 27 (2003) 147-161
135. Lee J.H., and Han Y. Ginsenoside Rg1 helps mice resist to disseminated candidiasis by TH1 type differentiation of CD4+ T cell. Int. Immunopharmacol. 6 (2006) 1424-1430
136. Lee T.M., and Marderosian A.D. Two-dimensional TLC analysis of ginsenosides from root of dwarf ginseng (Panax trifolius L.) Araliaceae. J. Pharm. Sci. 70 (1981) 89-91
137. Lee T.M., and Marderosian A.D. Studies on the constituents of dwarf ginseng. Phytother. Res. 2 (1988) 165-169
138. Lee Y., Saito H., Takagi K., Shibata S., Shoji J., and Kondo N. Pharmacological studies of Panacis japonici rhizome. II. Chem. Pharm. Bull. 25 (1977) 1391-1398
139. kipl. Cancer Lett. 110 (1996) 193-200
140. Lee S.J., Sung J.H., Lee S.J., Moon C.K., and Lee B.H. Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett. 144 (1999) 39-43
141. Lee S.-J., Ko W.-G., Kim J.-H., Sung J.-H., Lee S.-J., Moon C.-K., and Lee B.-H. Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 protease. Biochem. Pharmacol. 60 (2000) 677-685
142. Lee T.-F., Shiao Y.-J., Chen C.-F., and Wang L.C.H. Effect of ginseng saponins on β-amyloid-suppressed acetylcholine release from rat hippocampal slices. Planta Med. 67 (2001) 634-637
143. Lee D.S., Kim Y., Ko C.N., Cho K.H., Bae H.S., Lee K.S., Kim J.J., Park E.K., and Kim D.H. Fecal metabolic activities of herbal components to bioactive compounds. Arch. Pharm. Res. 25 (2002) 165-169
144. Lee J.W., Takano-Ishikawa Y., Watanabe J., Kobori M., Tsushida T., and Yamaki K. Effect of ginsenosides and red ginseng water extract on tumor necrosis factor-α production by rat peritoneal macrophages. Food Sci. Technol. Res. 8 (2002) 300-303
145. Lee M.-H., Jeong J.-H., Seo J.-W., Shin C.-G., Kim Y.-S., In J.-G., Yang D.-C., Yi J.-S., and Choi Y.-E. Enhanced triterpene and phytosterol biosynthesis in Panax ginseng overexpressing squalene synthase gene. Plant Cell Physiol. 45 (2004) 976-984
146. Lee E.-J., Ko E., Lee J., Rho S., Ko S., Shin M.-K., Min B.-I., Hong M.-C., Kim S.-Y., and Bae H. Ginsenoside Rg1 enhances CD4+ T-cell activities and modulates Th1/Th2 differentiation. Int. Immunopharmacol. 4 (2004) 235-244
147. Lee J.-Y., Shin J.-W., Chun K.-S., Park K.-K., Chung W.-Y., Bang Y.-J., Sung J.-H., and Surh Y.-J. Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from protopanaxadiol-type ginsenosides in mouse skin. Carcinogenesis 26 (2005) 359-367
148. Lee H., Gonzalez F.J., and Yoon M. Ginsenoside Rf, a component of ginseng, regulates lipoprotein metabolism through peroxisome proliferator-activated receptor α. Biochem. Biophys. Res. Commun. 339 (2006) 196-203
149. Lee S.H., Jung B.H., Kim S.Y., Lee E.H., and Chung B.C. The antistress effect of ginseng total saponin and ginsenoside Rg3 and Rb1 evaluated by brain polyamine level under immobilization stress. Pharmacol. Res. 54 (2006) 46-49
150. Lee W.-K., Kao S.T., Liu I.-M., and Cheng J.-T. Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in wistar rats. Clin. Exp. Pharmacol. Physiol. 33 (2006) 27-32
151. 2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons. Eur. J. Pharmacol. 536 (2006) 69-77
152. 11 in North American ginseng using high performance liquid chromatography with evaporate light scattering detection. J. Pharm. Biomed. Anal. 25 (2001) 257-265
153. Li W., and Fitzloff J.F. HPLC analysis of ginsenosides in the roots of Asian ginseng (Panax ginseng) and North American ginseng (Panax quinquefolius) with in-line photodiode array and evaporative light scattering detection. J. Liq. Chromatogr. Rel. Technol. 25 (2002) 29-41
154. Li W., and Fitzloff J.F. HPLC determination of ginsenosides content in ginseng dietary supplements using ultraviolet detection. J. Liq. Chrom. Rel. Technol. 25 (2002) 2485-2500
155. Li W., Gu C., Zhang H., Awang D.V.C., Fitzloff J.F., Fong H.H.S., and van Breemen R.B. Use of high-performance liquid chromatography-tandem mass spectrometry to distinguish Panax ginseng C. A. Meyer (Asian ginseng) and Panax quinquefolium L. (North American ginseng). Anal. Chem. 72 (2000) 5417-5422
156. + channels in ginsenosides-induced aortic relaxation in rats. J. Cardiovasc. Pharmacol. 37 (2001) 41-47
157. Li Q.C., Harkey M.R., Henderson G.L., Gershwin M.E., Stern J.S., and Hackman R.M. Quantitative determination of ginsenosides by high-performance liquid chromatography-tandem mass spectrometry. Phytochem. Anal. 12 (2001) 320-326
158. Li L., Sheng Y., Zhang J., Wang C., and Guo D.-A. HPLC determination of four active saponins from Panax notoginseng in rat serum and its application to pharmacokinetic studies. Biomed. Chromatogr. 18 (2004) 849-856
159. Li L., Zhang J., Sheng Y., Ye G., Guo H.-Z., and Guo D.-A. Liquid chromatographic method for determination of four active saponins from Panax notoginseng in rat urine using solid phase extraction. J. Chromatogr. B 808 (2004) 177-183
160. Li L., Tsao R., Dou J., Song F., Liu Z., and Liu S. Detection of saponins in extract of Panax notoginseng by liquid chromatography-electrospray ionisation-mass spectrometry. Anal. Chim. Acta 536 (2005) 21-28
161. Li L., Sheng Y., Zhang J., Wang C., and Guo D.-A. High-performance liquid chromatographic assay for the active saponins from Panax notoginseng in rat tissues. Biomed. Chromatogr. 20 (2006) 327-335
162. Li X., Sun J., Wang G., Hao H., Liang Y., Zheng Y., Yan B., and Sheng L. Simultaneous determination of panax notoginsenoside R1, ginsenoside Rg1, Rd, Re and Rb1 in rat plasma by HPLC/ESI/MS: Platform for the pharmacokinetic evaluation of total panax notoginsenoside, a typical kind of multiple constituent traditional Chinese medicine. Biomed. Chromatogr. 21 (2007) 735-746
163. Li X., Wang G., Sun J., Hao H., Xiong Y., Yan B., Zheng Y., and Sheng L. Pharmacokinetic and absolute bioavailability study of total panax notoginsenoside, a typical multiple constituent traditional Chinese medicine (TCM) in rats. Biol. Pharm. Bull. 30 (2007) 847-851
164. Ligor T., Ludwiczuk A., Wolski T., and Buszewski B. Isolation and determination of ginsenosides in American ginseng leaves and root extracts by LC-MS. Anal. Bioanal. Chem. 383 (2005) 1098-1105
165. 1. Chem. Pharm. Bull. 24 (1976) 253-261
166. Linsefors L., Björk L., and Mosbach K. Influence of elicitors and mevalonic acid on the biosynthesis of ginsenosides in tissue cultures of Panax ginseng. Biochem. Physiol. Pflanzen 184 (1989) 413-418
167. Liu C.-X., and Xiao P.-G. Recent advances on ginseng research in China. J. Ethnopharmacol. 36 (1992) 27-38
168. 3. Chin. J. Cancer Prev. Treat. 11 (2004) 957-958
169. Liu W.K., Xu S.X., and Che C.T. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci. 67 (2000) 1297-1306
170. Liu X., Ye W., Mo Z., Yu B., Zhao S., Wu H., Che C., Jiang R., Mak T.C.W., and Hsaio W.L.W. Five new ocotillone-type saponins from Gymnostemma pentaphyllum. J. Nat. Prod. 67 (2004) 1147-1151
171. Liu J., Xiao S., Shang W., Xu L., and Yang S. A new minor triterpene saponin from kaixin-san prescription. J. Asian Nat. Prod. 7 (2005) 643-648
172. Lou D.-W., Saito Y., and Jinno K. Solid-phase extraction and high-performance liquid chromatography for simultaneous determination of important bioactive ginsenosides in pharmaceutical preparations. Chromatographia 62 (2005) 349-354
173. Lou D.-W., Saito Y., and Jinno K. Simultaneous LC determination of ginsenosides using a modified extraction procedure and an improved step gradient program. Chromatographia 63 (2006) 31-37
174. Lou D.-W., Saito Y., Zarzycki P.K., Ogawa M., and Jinno K. Isocratic separation of ginsenosides by high-performance liquid chromatography on a diol column at subambient temperatures. Anal. Bioanal. Chem. 385 (2006) 96-104
175. Ludwiczuk A., Wolski T., and Berbeć S. Chromatographic analysis of ginsenosides occurring in the roots of American ginseng (Panax quinquefolium L.) and in Asian ginseng (Panax ginseng C. A. Meyer) preparations. J. Planar Chromatogr. 15 (2002) 147-150
176. Lui J.H.-C., and Staba E.J. The ginsenosides of various ginseng plants and selected products. J. Nat. Prod. 43 (1980) 340-346
177. Luo Z.-Y., Liu S.-P., Chen X.-H., Ruan Y., Luo J.-Q., Wen B., Liu C.-L., and Hu W.-X. Spatio-temporal expression pattern of six novel candidate genes in ginsenoside biosynthesis from Panax ginseng C. A. Meyer. J. Integr. Plant Biol. 47 (2005) 622-631
178. Ma Y.C., Zhu J., Benkrima L., Luo M., Sun L., Sain S., Kont K., and Plaut-Carcasson Y.Y. A comparative evaluation of ginsenosides in commercial ginseng products and tissue culture samples using HPLC. J. Herb Spices Med. Plants 3 (1995) 41-50
179. Ma W.G., Mitzutani M., Malterud K.E., Lu S.L., Ducrey B., and Tahara S. Saponins from the roots of Panax notoginseng. Phytochemistry 52 (1999) 1133-1139
180. Ma X.-Q., Liang X.-M., Xu Q., Zhang X.-Z., and Xiao H.-B. Identification of ginsenosides in roots of Panax ginseng by HPLC-APCI/MS. Phytochem. Anal. 16 (2005) 181-187
181. Ma X., Xiao H., and Liang X. Identification of ginsenosides in Panax quinquefolium by LC-MS. Chromatographia 64 (2006) 31-36
182. Matsuda H., Namba K., Fukuda S., Tani T., and Kubo M. Pharmacological study on Panax ginseng C. A. Meyer. III. Effects of red ginseng on experimental disseminated intravascular coagulation. 2. Effects of ginsenosideson blood coagulative and fibrinolytic systems. Chem. Pharm. Bull. 34 (1986) 1153-1157
183. Matsuura H., Kasai R., Tanaka O., Saruwatari Y., Fuwa T., and Zhou J. Further studies on dammarane-saponins of Sanchi-ginseng. Chem. Pharm. Bull. 31 (1983) 2281-2287
184. Min J.-K., Kim J.-H., Cho Y.-L., Maeng Y.-S., Lee S.-J., Pyun B.-J., Kim Y.-M., Park J.H., and Kwon Y.-G. 20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway. Biochem. Biophys. Res. Commun. 349 (2006) 987-994
185. 3, of red ginseng. Biol. Pharm. Bull. 18 (1995) 1197-1202
186. Morinaga O., Pulalun W., Fukuda N., Shan S.-J., Kanetsuki Y., Tanaka H., and Shoyama Y. Development of analytical system for using monoclonal antibodies. Curr. Top. Anal. Chem. 2 (2001) 147-158
187. Morinaga O., Tanaka H., and Shoyama Y. Enzyme-linked immunosorbent assay for the determination of total ginsenosides in ginseng. Anal. Lett. 39 (2006) 287-296
188. Morita T., Kasai R., Tanaka O., Zhou J., Tsungren Y., and Dhoji J. Saponins of Zu-Tziseng, rhizomes of Panax japonicus C. A. Meyer var. major (Burk.) C.Y. Wu et K.M. Feng collected in Yunnan, China. Chem. Pharm. Bull. 30 (1982) 4341-4345
189. Morita T., Kasai R., Kohda H., Tanaka O., Zhou J., and Tsungren Y. Chemical and morphological study on Chinese Panax japonicus C. A. Meyer (Zhujie-Shen). Chem. Pharm. Bull. 31 (1983) 3205-3209
190. Nagata H., Kikuchi Y., Tode T., Hirata J., Kita T., Ishii K., Kudoh K., Nagata I., and Shinomiya N. Inhibitory effects of ginsenoside Rh-2 on tumour growth in nude mice bearing human ovarian cancer cells. Jpn. J. Cancer Res. 89 (1998) 733-740
191. Nakamura S., Sugimoto S., Matsuda H., and Yoshikawa M. Structures of dammarane-type triterpene triglycosides from the flower buds of Panax ginseng. Heterocycles 71 (2007) 577-588
192. Nakamura S., Sugimoto S., Matsuda H., and Yoshikawa M. Medicinal flowers. XVII. New dammarane-type triterpene glycosides from flower buds of American ginseng, Panax quinquefolium L. Chem. Pharm. Bull. 55 (2007) 1342-1348
193. 1 in the rat. Chem. Pharm. Bull. 31 (1983) 292-298
194. 1 in the rat. Chem. Pharm. Bull. 31 (1983) 1059-1066
195. Odashima S., Ohta T., Kohno H., Matsuda T., Kitagawa I., Abe H., and Arichi S. Control of phenotypic-expression of cultured B-16 melanoma-cells by plant glycosides. Cancer Res. 45 (1985) 2781-2784
196. Oh M., Choi S.H., Chung Y.H., Kim K.W., Kim S.I., Kim D.K., and Kim N.D. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int. J. Oncol. 14 (1999) 869-875
197. Oh G.S., Pae H.O., Choi B.M., Seo E.A., Kim D.H., Shin M.K., Kim J.D., Kim J.B., and Chung H.T. 20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-κB in RAW 264.7 macrophages stimulated with lipopolysaccharide. Cancer Lett. 205 (2004) 23-29
198. Ota T., Maeda M., and Odashima S. Mechanism of action of ginsenoside-Rh2; uptake and metabolism of ginsenoside-Rh2 by cultured B16 melanoma cells. J. Pharm. Sci. 80 (1991) 1141-1146
199. Pan H.-J., Lin Y., Chen Y.E., Vance D.E., and Leiter E.H. Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: Relation to dysregulated phosphatidylcholine metabolism. Vasc. Pharmacol. 45 (2006) 65-71
200. Park M.K., Kim B.K., Park J.H., Shin Y.G., and Cho K.H. High performance liquid chromatographic determination of ginsenosides using photoreduction fluorescence detection. J. Liq. Chromatogr. 18 (1995) 2077-2088
201. Park Y.C., Lee C.H., Kang H.S., Kim K.W., Chung H.T., and Kim H.D. Ginsenoside Rh1 and Rh2 inhibit the induction of nitric oxide synthesisin murine peritoneal macrophages. Biochem. Mol. Biol. Int. 40 (1996) 751-757
202. Park H.J., Lee H.J., Song Y.B., and Park K.H. Effects of dietary supplementation of lipophilic fraction from Panax ginseng on cGMP and cAMP in rat platelets and on blood coagulation. Biol. Pharm. Bull. 19 (1996) 1434-1439
203. Park M.K., Park J.H., Han S.B., Shin Y.G., and Park I.H. High-performance liquid chromatographic analysis of ginseng saponins using evaporate light scattering detection. J. Chromatogr. A 736 (1996) 77-81
204. Park J.A., Lee K.Y., Oh Y.J., Kim K.-W., and Lee S.K. Activation of caspase-3 protease via a Bcl-2-insensitive pathway during the process of ginsenoside Rh2-induced apoptosis. Cancer Lett. 121 (1997) 73-81
205. Park I.H., Han S.B., Kim J.M., Piao L., Kwon S.W., Kim N.Y., Kang T.L., Park M.K., and Park J.H. Four new acetylated ginsenosides from processed ginseng (sun ginseng). Arch. Pharm. Res. 25 (2002) 837-841
206. Park I.H., Kim N.Y., Han S.B., Kim J.M., Kwon S.W., Kim H.J., Park M.K., and Park J.H. Three new dammarane glycosides from heat processed ginseng. Arch. Pharm. Res. 25 (2002) 428-432
207. Park I.H., Piao L.Z., Kwon S.W., Lee Y.J., Cho S.Y., Park M.K., and Park J.H. Cytotoxic dammarane glycosides from processed ginseng. Chem. Pharm. Bull. 50 (2002) 538-540
208. Park E.-K., Choo M.-K., Kim E.-J., Han M.J., and Kim D.-H. Antiallergic activity of ginsenoside Rh2 (Pharmacognosy). Biol. Pharm. Bull. 26 (2003) 1581-1584
209. Park E.-K., Choo M.-K., Han M.J., and Kim D.-H. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int. Arch. Allergy Immunol. 133 (2004) 113-120
210. Park E.-K., Shin Y.-W., Lee H.-U., Kim S.-S., Lee Y.-C., Lee B.-Y., and Kim D.-H. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosynthesis of RAW 264.7 cells induced by lipopolysaccharide. Biol. Pharm. Bull. 28 (2005) 652-656
211. Park E.-J., Zhao Y.-Z., Kim J., and Sohn D.H. A ginsenoside metabolite 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol, triggers apoptosis in activated rat hepatic stellate cells via caspase-3 activation. Planta Med. 72 (2006) 1250-1253
212. Perry E.K. The cholinergic hypothesis-ten years on. Br. Med. Bull. 42 (1986) 63-69
213. Pietta P., Mauri P., and Rava A. Improved high-performance liquid high-performance liquid chromatography method for the analysis of ginsenosides in Panax ginseng extracts and products. J. Chromatogr. 356 (1986) 212-219
214. Pietta P., Mauri P., and Rava A. Hydrolysis of ginsenosides in artificial gastric fluid monitored by high-performance liquid chromatography. J. Chromatogr. 362 (1986) 291-297
215. Plaitakis A., and Shashidharan P. Glutamate transport and metabolism in dopaminergic neurons of substania nigra: Implications for the pathogenesis of Parkinson's disease. J. Neurol. 247 (2000) 1125-1135
216. Plohmann B., Bader G., Hiller K., and Franz G. Immunomodulatory and anti-tumoral effects of triterpenoid saponins. Pharmazie 52 (1997) 953-957
217. Popovich D.G., and Kitts D.D. Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukaemia (THP-1) cell line. Arch. Biochem. Biophys. 406 (2002) 1-8
218. Popovich D.G., and Kitts D.D. Generation of ginsenosides Rg3 and Rh2 from North American ginseng. Phytochemistry 65 (2004) 337-344
219. Popovich D.G., and Kitts D.D. Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolium) extract induced cytotoxicity in intestinal Caco-2 cells. J. Biochem. Mol. Toxicol. 18 (2004) 143-149
220. Putalun W., Fukuda N., Tanaka H., and Shoyama Y. A one-step immunochromatographic assay for detecting ginsenosides Rb1 and Rg1. Anal. Bioanal. Biochem. 378 (2004) 1338-1341
221. 1 on rat. Anal. Biochem. 352 (2006) 87-96
222. 1H NMR. Acta Pharm. Sin. 34 (1999) 58-62
223. Qui F., Ma Z.Z., Xu S., Yao X.S., Chen Y.J., and Che Z.T. Studies on dammarane-type saponins in the flower-buds of Panax ginseng C. A. Meyer. J. Asian Nat. Prod. Res. 1 (1998) 119-123
224. Qui F., Ma Z.-Z., Xu S.-X., Yao X.-S., Che C.-T., and Chen Y.-J. A pair of 24-hydroperoxyl epimeric dammarane saponins from flower-buds of Panax ginseng. J. Asian Nat. Prod. Res. 3 (2001) 235-240
225. +-affected mesencephalic dopaminergic cells. J. Neural Transm. 111 (2004) 37-45
226. Radad K., Gille G., Moldzio R., Saito H., and Rausch W.-D. Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Res. 1021 (2004) 41-53
227. Radad K., Gille G., Liu L., and Rausch W.-D. Use of ginseng in medicine with emphasis on neurodegenerative disorders. J. Pharmacol. Sci. 100 (2006) 175-186
228. Rausch W.-D., Liu S., Gille G., and Radad K. Neuroprotective effects of ginsenosides. Acta Neurobiol. Exp. 66 (2006) 369-375
229. Razmovski-Naumovski V., Huang T.H.-W., Tran V.H., Li G.Q., Duke C.C., and Roufogalis B.D. Chemistry and pharmacology of Gymnostemma pentaphyllum. Phytochem. Rev. 4 (2005) 197-219
230. Reichlin S. Neuroendocrine-immune interactions. N. Eng. J. Med. 329 (1993) 1246-1253
231. Ren G., and Chen F. Simultaneous quantification of ginsenosides in American ginseng (Panax quinquefolium) root powder by visible/near-infrared reflectance spectroscopy. J. Agric. Food Chem. 47 (1999) 2771-2775
232. Rhule A., Navarro S., Smith J.R., and Shepherd D.M. Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264.7 cells. J. Etnopharmacol. 106 (2006) 121-128
233. Ro J.Y., Ahn Y.S., and Kim K.H. Inhibitory effect of ginsenoside on the mediator release in the guines pig lung mast cells activated by specific antigen-antibody reactions. Int. J. Immunopharmacol. 20 (1998) 625-641
234. 1. Planta Med. 67 (2001) 533-537
235. Ryu J.-H., Park J.-H., Eun J.-H., Jung J.-H., and Sohn D.H. A dammarane glycoside from Korean red ginseng. Phytochemistry 44 (1997) 931-933
236. Said S.I., Pakbaz H., Berisha H.I., and Raza S. NMDA receptor activation: Critical role in antioxidant tissue injury. Free Radic. Bio. Med. 28 (2000) 1300-1302
237. Samukawa K., Yamashita H., Matsuda H., and Kubo M. Simultaneous analysis of saponins in ginseng radix by high performance liquid chromatography. Chem. Pharm. Bull. 43 (1995) 137-141
238. 3 and 20-glucoginsenoside-Rf. Chem. Pharm. Bull. 26 (1978) 1694-1697
239. 2, -Rc and -Rd. Chem. Pharm. Bull. 22 (1974) 421-428
240. 2. Chem. Pharm. Bull. 22 (1974) 2407-2412
241. Sato K., Mochizuki M., Saiki I., Yoo Y.C., and Samukawa K. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside Rb2. Biol. Pharm. Bul. 17 (1994) 635-639
242. Schulten H.-R., and Soldati F. Identification of ginsenosides from Panax ginseng in fractions obtained by high-performance liquid chromatography by field desorption mass spectrometry, multiple internal reflection infrared spectroscopy and thin layer chromatography. J. Chromatogr. 212 (1981) 37-49
243. Schupp M., Clemenz M., Gineste R., Witt H., Janke J., Helleboid S., Hennuer N., Ruiz P., Unger T., Staels B., and Kintscher U. Molecular characterization of new selective peroxisome proliferator-activated receptor γ modulators with angiotensin receptor blocking activity. Diabetes 54 (2005) 3442-3452
244. Scott G.I., Colligan P.B., Ren B.H., and Ren J. Ginsenosides Rb1 and Re decrease cardiac contraction in adult rat ventricular myocytes: Role of nitric oxide. Br. J. Pharmacol. 134 (2001) 1159-1165
245. Semple R.K., Chatterjee V.K.K., and O'Rahilly S. PPAR γ and human metabolic disease. J. Clin. Invest. 116 (2006) 581-588
246. 2 and C/EBPα gene expression. Life Sci. 80 (2007) 618-625
247. Shangguan D., Han H., Zhao R., Zhao Y., Xiong S., and Liu G. New method for high-performance liquid chromatographic separation and fluorescence detection of ginsenosides. J. Chromatogr. A 910 (2001) 367-372
248. Shibata S. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J. Korean Med. Sci. 16 Suppl. (2001) S28-S37
249. Shibata S., Tanaka O., Ando T., Sado M., Tsushima S., and Ohsawa T. Chemical studies on oriental plant drugs. XIV. Protopanaxadiol, a genuin sapogenin of ginseng saponins. Chem. Pharm. Bull. 14 (1966) 595-600
250. Shibata S., Tanaka O., Shoji J., and Saito H. In: Wagner H., Hikino H., and Farnsworth N.R. (Eds). Economic and Medicinal Plant Research Vol. 1 (1985), Academic Press, London 217-284
251. 3. Jpn. J. Cancer Res. 87 (1996) 357-362
252. Shoyama Y., Tanaka H., and Fukuda N. Monoclonal antibodies against naturally occurring bioactive compounds. Cytotechnology 31 (1999) 9-27
253. Shu Y.Y., Ko M.Y., and Chang Y.S. Microwave-assisted extraction of ginsenosides from ginseng root. Microchem. J. 74 (2003) 131-139
254. Sievenpiper J.L., Arnason J.T., Leiter L.A., and Vuksan V. Variable effects of American ginseng: A batch of American ginseng (Panax quinquefolius L.) with a depressed ginsenoside profile does not affect postprandial glycemia. Eur. J. Clin. Nutr. 57 (2003) 243-248
255. Sievenpiper J.L., Arnason J.T., Leiter L.A., and Vuksan V. Null and opposing effects of Asian ginseng (Panax ginseng C. A. Meyer) on acute glycemia: Results of two acute dose escalation studies. J. Am. Coll. Nutr. 22 (2003) 524-532
256. Sievenpiper J.L., Arnason J.T., Leiter L.A., and Vuksan V. Decreasing, null and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices in healthy humans: The role of ginsenosides. J. Am. Coll. Nutr. 23 (2004) 248-258
257. Soldati F., and Sticher O. HPLC separation and quantitative determination of ginsenosides from Panax ginseng, Panax quinquefolium and from ginseng drug preparations. Planta Med. 38 (1980) 348-357
258. Soldati F., and Tanaka O. Panax ginseng: Relation between age of plant and content of ginsenosides. Planta Med. 50 (1984) 351-352
259. Song F., Liu Z., Liu S., and Cai Z. Differentiation and identification of ginsenoside isomers by electrospray ionization tandem mass spectrometry. Anal. Chim. Acta 531 (2005) 69-77
260. Sotaniemi E.A., Haapakoski E., and Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 18 (1995) 1373-1375
261. Staels B., and Auwerx J. Regulation of apo A-I gene expression by fibrates. Atherosclerosis 137 Suppl. (1998) S19-S23
262. Sticher O. Getting to the root of ginseng. Chemtech 28 (1998) 26-32
263. Sugaya A., Yuzurihara M., Tsuda T., Yasuda K., Kajiwara K., and Sugay A.E. Proliferative effect of ginseng saponin on neurite extension of primary cultured neurons of the rat cerebral cortex. J. Ethnopharmacol. 22 (1988) 173-181
264. 1 and aglycone protopanaxatriol in rat plasma by liquid chromatography-mass spectrometry after solid phase extraction. J. Pharm. Biomed. Anal. 38 (2005) 126-132
265. Sun H., Ye Y., and Pan Y. Immunological-adjuvant saponins from the roots of Panax notoginseng. Chem. Biodiver. 2 (2005) 510-515
266. Sun H., Yang Z., and Ye Y. Structure and biological activity of protopanaxatriol-type saponins from the roots of Panax notoginseng. Int. Immunopharmacol. 6 (2006) 14-25
267. Sung J., Han K.H., Zo J.H., Park H.J., Kim C.H., and Oh B.H. Effects of red ginseng upon vascular endothelial function in patients with essential hypertension. Am. J. Chin. Med. 28 (2000) 205-216
268. Takaki A., Huang Q.H., Somogyvari-Vigh A., and Arimura A. Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation 1 (1994) 335-342
269. Takei M., Tachikawa E., Hasegawa H., and Lee J.-J. Dendritic cells maturation promoted by M1 and M4, end products of steroidal ginseng saponins metabolized in digestive tracts, drive a potent Th1 polarization. Biochem. Pharmacol. 68 (2004) 441-452
270. 1 in rats. Chem. Pharm. Bull. 30 (1982) 2196-2201
271. Tanaka O., and Yahara S. Dammarane saponins of leaves of Panax pseudo-ginseng subsp. himalaicus. Phytochemistry 17 (1978) 1353-1358
272. Tanaka O., Morita T., Kasai R., Kinouchi J., Sanada S., Ida Y., and Shoji J. Study on saponins of rhizomes of Panax pseudo-ginseng subsp. himalaicus collected at Tzatogang and Pari-la, Bhutan-Himalaya. Chem. Pharm. Bull. 33 (1985) 2323-2330
273. Tanaka H., Fukuda N., and Shoyama Y. Formation of monoclonal antibody against a major ginseng component, ginsenoside Rb1 and its characterization. Cytotechnology 29 (1999) 115-120
274. Tanaka O., Han E.-C., Yamaguchi H., Matsuura H., Murakami T., Taniyama T., and Yoshikawa M. Saponins of plants of Panax species collected in central Nepal, and their chemotaxonomical significance. III. Chem. Pharm. Bull. 48 (2000) 889-892
275. Tanaka H., Fukuda N., and Shoyama Y. Identification and differentiation of Panax species using ELISA, RAPD and eastern blotting. Phytochem. Anal. 17 (2006) 46-55
276. Tani T., Kubo M., Katsuki T., Higashino M., Hayashi T., and Arichi S. Histochemistry. II. Ginsenosides in ginseng (Panax ginseng C. A. Meyer, root). J. Nat. Prod. 44 (1981) 401-407
277. Tansakul P., Shibuya M., Kushiro T., and Ebizuka Y. Dammarenediol-II synthase, the first dedicated enzyme for ginsenoside biosynthesis, in Panax ginseng. FEBS Lett. 580 (2006) 5143-5149
278. Tawab M.A., Bahr U., Karas M., Wurglics M., and Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab. Dispos. 31 (2003) 1065-1071
279. Tobin J.F., and Freeman L.P. Nuclear receptors as drug targets in metabolic diseases: New approaches to therapy. Trends Endocrinol. Metab. 17 (2006) 284-290
280. 2 on the growth of human ovarian cancer cells in nude mice. J. Cancer Res. Clin. Oncol. 120 (1993) 24-26
281. Tohda C., Matsumoto N., Zou K., Meselhy M.R., and Komatsu K. Axonal and dendritic extension by protopanaxadiol-type saponins from ginseng drugs in SK-N-SH cells. Jpn. J. Pharmacol. 90 (2002) 254-262
282. Torssell K.B.G. Natural Product Chemistry. A Mechanistic and Biosynthetic Approach to Secondary Metabolism (1983), John Wiley & Sons Ltd., New York
283. Tran Q.L., Adnyana I.K., Tezuka Y., Nagaoka T., Tran Q.K., and Kadota S. Triterpene saponins from Vietnamese ginseng (Panax vietnamensis) and their hepatocytoprotective activity. J. Nat. Prod. 64 (2001) 456-461
284. Tran Q.L., Than M.M., Tezuka Y., Banskota A.H., Kouda K., Watanabe H., Zhu S., Komatsu K., Thet M.M., Swe T., Maruyama Y., and Kadota S. Wild ginseng grows in Myanmar. Chem. Pharm. Bull. 51 (2003) 679-682
285. Tsang D., Yeung H.W., Tso W.W., and Peck H. Ginseng saponins: Influence on neurotransmitter uptake in rat brain synaptosomes. Planta Med. 3 (1985) 211-224
286. Uvarova N.I., Makhan'kova V.V., Malinovskaya G.V., Samoshina N.F., Atopkina L.N., Likhatskaya G.N., Kim N.Y., Anisimov M.M., and Elyakov G.B. Triterpene glycosides from wild and cultivated ginseng occurring in maritime territory: Chemical characterization, comparative quantitative analysis, and biological activity study. Pharm. Chem. J. 34 (2000) 122-129
287. van Breemen R.B., Huang C.R., Lu Z.Z., Rimando A., Fong H.H.S., and Fitzloff J.F. Electrospray liquid chromatography/mass spectrometry of ginsenosides. Anal. Chem. 67 (1995) 3985-3989
288. van Kampen J., Robertson H., Hagg T., and Drobitch R. Neoroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease. Exp. Neurol. 184 (2003) 521-529
289. Vanhaelen-Fastré R., Faes M.L., and Vanhaelen M.H. High-performance thin-layer chromatographic determination of six major ginsenosides in Panax ginseng. J. Chromatogr. A 868 (2000) 269-276
290. Vuksan V., Stavro M.P., Sievenpiper J.L., Koo V.Y.Y., Wong E., Beljan-Zdravkovic U., Francis T., Jenkins A.L., Leiter L.A., Josse R.G., and Xu Z. Americxan ginseng improves glycemia in individuals with normal glucose tolerance: Effect of dose and time escalation. J. Am. Coll. Nutr. 19 (2000) 738-744
291. Vuksan V., Sievenpiper J.L., Wong E., Xu Z., Beljan-Zdravkovic U., Arnason J.T., Assinewe V., Stavro M.P., Francis T., Jenkins A.L., Leiter L.A., and Francis T. Americxan ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals. Am. J. Clin. Nutr. 73 (2001) 753-758
292. Wakabayashi C., Hasegawa H., Murata J., and Saiki I. In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oncol. Res. 9 (1997) 411-417
293. Wakabayashi C., Murakami K., Hasegawa H., Murata J., and Saiki I. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. Biochem. Biophys. Res. Commun. 246 (1998) 725-730
294. Wan J.B., Li P., Li S., Wang Y., Dong T.T.-X., and Tsim K.W.-K. Simultaneous determination of 11 saponins in Panax notoginseng using HPLC-ELSD and pressurized liquid extraction. J. Sep. Sci. 29 (2006) 2190-2196
295. Wan J.B., Yang F.Q., Li S.P., Wang Y.T., and Cui X.M. Chemical characteristics for different parts of Panax notoginseng using pressurized liquid extraction and HPLC-ELSD. J. Pharm. Biomed. Anal. 41 (2006) 1596-1601
296. Wan J.B., Li S., Chen J.-M., and Wang Y.-T. Chemical characteristics of three medicinal plants of the Panax genus determined by HPLC-ELSD. J. Sep. Sci. 30 (2007) 825-832
297. Wang J.-Y., Li W., and Li X. A new saponin from the leaves and stems of Panax quinquefolium L. collected in Canada. J. Asian Nat. Prod. Res. 1 (1998) 93-97
298. Wang J., Sakuma T., Asafu-Adjaye E., and Shiu G.K. Determination of ginsenosides in plant extracts from Panax ginseng L. and Panax quinquefolius L. by LC/MS/MS. Anal. Chem. 71 (1999) 1579-1584
299. Wang H.-C., Chen C.-R., and Chang C.J. Carbon dioxide extraction of ginseng root hair oil and ginsenosides. Food Chem. 72 (2001) 505-509
300. Wang J.-Y., Li W., Sha Y., Tezuka Y., Kadato S., and Li X. Triterpenoid saponins from leaves and stems of Panax quinquefolium L. J. Asian Nat. Prod. Res. 3 (2001) 123-130
301. 9 from leaves and stems of Panax quinquefolium L. J. Asian Nat. Prod. Res. 3 (2001) 293-297
302. 3, a new triterpenoid saponin from the fruits of Panax ginseng C. A. Mey. J. Asian Nat. Prod Res. 6 (2004) 289-293
303. Wang W., Zhang Z.-Y., and Zhong J.-J. Enhancement of ginsenoside biosynthesis in high-density cultivation of Panax notoginseng cells by various strategies of methyl jasmonate elicitation. Appl. Microbiol. Biotechnol. 67 (2005) 752-758
304. Wang C.-Z., Wu J.A., McEntee E., and Yuan C.-S. Saponins composition in American ginseng leaf and berry assayed by high-performance liquid chromatography. J. Agric. Food Chem. 54 (2006) 2261-2266
305. Wang W., Zhao Z.-J., Xu Y., Qian X., and Zhong J.-J. Efficient induction of ginsenoside biosynthesis and alteration of ginsenoside heterogeneity in cell cultures of Panax notoginseng by using chemically synthesized 2-hydroxyethyl jasmonate. Appl. Microbiol. Biotechnol. 70 (2006) 298-307
306. Wang W., Zhao Z.-J., Rayburn E.R., Hill D.L., Wang H., and Zhang R. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother. Pharmacol. 59 (2007) 589-601
307. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes. Diabetes Care 27 (2004) 1047-1053
308. Wills R.B.H., and Stuart D.L. Production of high quality Australian ginseng. A report for the Rual Industries Research and Development Corporation (RIRDC) (2001), RIRDC Publication No. 01/170. ACT, Kingston 1-35
309. Wood J.A., Bernards M.A., Wan W., and Charpentier. Extraction of ginsenosides from North American ginseng using modified supercritical carbon dioxide. J. Supercrit. Fluids 39 (2006) 40-47
310. Wu C.F., Bi X.L., Yang J.Y., Zhan J.Y., Dong Y.X., Wang J.H., Wang J.M., Zhang R., and Li X. Differential effects of ginsenosides on NO and TNF-α production by LPS-activated N9 microglia. Int. Immunopharmacol. 7 (2007) 313-320
311. Xie J.T., Aung H.H., Wu J.A., Attel A.S., and Yuan C.S. Effects of American ginseng berry extract on blood glucose levels in ob/ob mice. Am. J. Chinese Med. 30 (2002) 187-194
312. Xie J.T., Zhou Y.-P., Dey L., Attele A.S., Wu J.A., Gu M., Polonsky K.S., and Yuan C.-S. Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine 9 (2002) 254-258
313. Xie J.-T., Mehendale S.R., Wang A., Han A.H., Wu J.A., Osinski J., and Yuan C.-S. American ginseng leaf: Ginsenoside analysis and hypoglycemic activity. Pharmacol. Res. 49 (2004) 113-117
314. Xie J.T., Mehendale S.R., Li X., Quigg R., Wang X., Wang C.Z., Wu J.A., Aung H.H., Rue P.A., Bell G.I., and Yuan C.S. Anti-diabetic effect and ginsenoside Re in ob/ob mice. Biochim. Biophys. Acta 1740 (2005) 319-325
315. Xie H.-T., Wang G.-J., Sun J.-G., Tucker I., Zhao X.-C., Xie Y.-Y., Li H., Jiang X., Wang R., Xu M.-J., and Wang W. High-performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetik studies. J. Chromatogr. B 818 (2005) 167-173
316. Xue J.-F., Liu Z.-J., Hu J.-F., Chen H., Zhang J.-T., and Chen N.-H. Ginsenoside Rb1 promotes neurotransmitter release by modulating phosphyrolation of synapsis through a cAMP-dependent protein kinase pathway. Brain Res. 1106 (2006) 91-98
317. Yahara S., Tanaka O., and Tetsuya K. Saponins of the leaves of Panax ginseng C. A. Meyer. Chem. Pharm. Bull. 24 (1976) 2204-2208
318. 1. Chem. Pharm. Bull. 24 (1976) 3212-3213
319. 10. Chem. Pharm. Bull. 25 (1977) 2041-2047
320. Yahara S., Tanaka O., and Nishioka I. Dammarane type saponins of leaves of Panax japonicus C. A. Meyer (2): Saponins of the specimens collected in Tottori-ken, Kyoto-shi, and Niigata-ken. Chem. Pharm. Bull. 26 (1978) 3010-3016
321. Yahara S., Kaji K., and Tanaka O. Further study on dammarane-type saponins of roots, leaves, flower-buds, and fruits of Panax ginseng C. A. Meyer. Chem. Pharm. Bull. 27 (1979) 88-92
322. Yamaguchi Y., Haruta K., and Kobayashi H. Effects of ginsenosides on impaired performance induced in the rat by scopolamine in a radial-arm maze. Psychoneuroendrocrinology 20 (1995) 645-653
323. Yamaguchi Y., Higashi M., and Kobayashi H. Effects of ginsenosides on impaired performance caused by scopolamine in rats. Eur. J. Pharmacol. 312 (1996) 149-151
324. 1 on the performance impaired by scopolamine in rats. Biomed. Res. 17 (1996) 487-490
325. Yamaguchi Y., Higashi M., and Kobayashi H. Effects of ginsenosides on maze performance and brain choline acetyltransferase activity in scopolamine-treated young rats and aged rats. Eur. J. Pharmacol. 329 (1997) 37-41
326. Yang S.Y., Kim H.K., Lefeber A.W.M., Erkelens C., Angelova N., Choi Y.H., and Verporte R. Application of two-dimensional nuclear magnetic resonance spectroscopy to quality control of ginseng commercial products. Planta Med. 72 (2006) 364-369
327. Yap K.Y.-L., Chan S.Y., Chan Y.W., and Lim C.S. Overview on the analytical tools for quality control of natural product-based supplements: A case study of ginseng. Assay Drug Deve. Technol. 3 (2005) 683-699
328. 2 from Panax ginseng using enzyme immunoassay. Chem. Pharm. Bull. 46 (1998) 1144-1147
329. Yoon M., Lee H., Jeong S., Kim J.-J., Nicol C.J., Nam K.W., Kim M., Cho B.G., and Oh G.T. Peroxisome proliferator-activated receptor α is involved in the regulation of lipid metabolism by ginseng. Br. J. Pharmacol. 138 (2003) 1295-1302
330. Yoshikawa M., Murakami T., Ueno T., Hirokawa N., Yashiro K., Murakami N., Yamahara J., Matsuda H., Saijoh R., and Tanaka O. Bioactive saponins and glycosides. IX. Notoginseng (2): Structures of five new dammarane-type triterpene oligoglycosides, Notoginsenosides-E, -G, -H, -I, and -J, and a novel acetylenic fatty acid glycoside, Notoginsenic acid β-sophoroside, from the dried root of Panax notoginseng (Burk.) F. H. Chen. Chem. Pharm. Bull. 45 (1997) 1056-1062
331. Yoshikawa M., Murakami T., Ueno T., Yashiro K., Hirokawa N., Murakami N., Yamahara J., Matsuda H., Saijoh R., and Tanaka O. Bioactive saponins and glycosides. VIII. Notoginseng (1): New dammarane-type triterpene oligoglycosides, Notoginsenosides-A, -B, -C, and -D, from the dried root of Panax notoginseng (Burk.) F. H. Chen. Chem. Pharm. Bull. 45 (1997) 1039-1045
332. Yoshikawa M., Murakami T., Yashiro K., Yamahara J., Matsuda H., Saijoh R., and Tanaka O. Bioactive saponins and glycosides. XI. Structures of new dammarane-type triterpene oligoglycosides, Quinquenosides I, II, III, IV, and V, from American ginseng, the roots of Panax quinquefolium L. Chem. Pharm. Bull. 46 (1998) 647-654
333. Yoshikawa M., Morikawa T., Yashiro K., Murakami T., Yamahara J., and Matsuda H. Bioactive saponins and glycosides. XIX. Notoginseng (3): Immunological adjuvant activity of notoginsenosides and related saponins: Structures of notoginsenosides-L, -M, and -N from the roots of Panax notoginseng (Burk.) F. H. Chen. Chem. Pharm. Bull. 49 (2001) 1452-1456
334. Yoshikawa M., Sugimoto S., Nakamura S., and Matsuda H. Medicinal flowers. XI. Structures of new dammarane-type triterpene diglycosides with hydroperoxide group from flower buds of Panax ginseng. Chem. Pharm. Bull. 55 (2007) 571-576
335. Yoshikawa M., Sugimoto S., Nakamura S., Sakumae H., and Matsuda H. Medicinal flowers. XVI. New dammarane-type triterpene tetraglycosides and gastroprotective principles from flower buds of Panax ginseng. Chem. Pharm. Bull. 55 (2007) 1034-1038
336. Yu J.-L., Dou D.-Q., Chen X.-H., Yang H.-Z., Guo N., and Cheng G.-F. Protopanaxatriol-type ginsenosides differentially modulate type 1 and type 2 cytokines production from murine splenocytes. Planta Med. 71 (2005) 202-207
337. Yue C.-J., and Zhong J.-J. Purification and characterisation of UDPG: Ginsenoside Rd glucosyltransferase from suspended cells of Panax notoginseng. Process Biochem. 40 (2005) 3742-3748
338. 3. Biochem. Pharmacol. 72 (2006) 437-445
339. Yun T.K. Panax ginseng-a non-organ-specific cancer preventive?. Lancet Oncol. 2 (2001) 49-55
340. Yun T.K. Brief introduction of Panax ginseng C.A. Meyer. J. Korean Med. Sci. 16 Suppl. (2001) S3-S5
341. Yun T.K. Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat. Res. 523/524 (2003) 63-74
342. Yun S.N., Moon S.J., Ko S.K., Im B.O., and Chung S.H. Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice. Arch. Pharm. Res. 27 (2004) 790-796
343. Zhang H., and Cheng Y. Solid-phase extraction and liquid chromatography-electrospray mass spectrometric analysis of saponins in Chinese patent medicine of formulated Salvia miltiorrhizae and Panax notoginseng. J. Pharm. Biomed. Anal. 40 (2006) 429-432
344. Zhang H., Lu Z., Tan G.T., Qiu S., Farnsworth N.R., Pezzuto J.M., and Fong H.H.S. Polyacetyleneginsenoside-Ro, a novel triterpene saponin from Panax ginseng. Tetrahedron Lett. 43 (2002) 973-977
345. 1. Chem. Pharm. Bull. 29 (1981) 2844-2850
346. Zhu S., Zou K., Fushimi H., Cai S., and Komatsu K. Comparative study on triterpene saponins of ginseng drugs. Planta Med. 70 (2004) 666-677
347. Zou K., Zhu S., Meselhy M.R., Tohda C., Cai S., and Komatsu K. Dammarane-type saponins from Panax japonicus and their neurite outhgrowth activity in SK-N-SH cells. J. Nat. Prod. 65 (2002) 1288-1292